Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oakes

Showing results (21-30 of 119) with videos related to

Pageof 12
Sort By:
Neurology|October 10, 2014
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome StudyDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
JAMA Neurology|June 9, 2017
Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal CohortDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Archives of Neurology|August 18, 2004
(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosisDanna L Jennings, John P Seibyl, David Oakes, et al.
Neurology|August 1, 2015
Author ResponseDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Bjpsych Open|August 14, 2023
Military culture and collaborative decision-making in mental healthcare: cultural, communication and policy considerationsEmily B H Treichler, Samantha J Reznik, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2020
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-upAndrew Siderowf, Danna Jennings, Matthew Stern, et al.
Clinical Neuropharmacology|October 22, 2005
Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instrumentsKelvin L Chou, Susan Messing, David Oakes, et al.
JAMA Neurology|September 4, 2013
Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington diseaseKaren Marder, Yian Gu, Shirley Eberly, et al.
Journal of Huntington'S Disease|October 8, 2015
Informativeness of Early Huntington Disease Signs about Gene StatusEmily Oster, Shirley W Eberly, E Ray Dorsey, et al.
Movement Disorders Clinical Practice|October 11, 2021
Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsSheng Luo, Haotian Zou, Christopher G Goetz, et al.
Pageof 12

Showing results (21-30 of 119) with videos related to

Sort By:
Pageof 12
Neurology|October 10, 2014
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome StudyDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
JAMA Neurology|June 9, 2017
Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal CohortDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Archives of Neurology|August 18, 2004
(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosisDanna L Jennings, John P Seibyl, David Oakes, et al.
Neurology|August 1, 2015
Author ResponseDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Bjpsych Open|August 14, 2023
Military culture and collaborative decision-making in mental healthcare: cultural, communication and policy considerationsEmily B H Treichler, Samantha J Reznik, David Oakes, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2020
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-upAndrew Siderowf, Danna Jennings, Matthew Stern, et al.
Clinical Neuropharmacology|October 22, 2005
Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instrumentsKelvin L Chou, Susan Messing, David Oakes, et al.
JAMA Neurology|September 4, 2013
Relationship of Mediterranean diet and caloric intake to phenoconversion in Huntington diseaseKaren Marder, Yian Gu, Shirley Eberly, et al.
Journal of Huntington'S Disease|October 8, 2015
Informativeness of Early Huntington Disease Signs about Gene StatusEmily Oster, Shirley W Eberly, E Ray Dorsey, et al.
Movement Disorders Clinical Practice|October 11, 2021
Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsSheng Luo, Haotian Zou, Christopher G Goetz, et al.
Pageof 12